1. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma by René-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, Anne Julian, Catherine Thieblemont, Pierre Vera, Serge Bologna, Josette Brière, Jean-Philippe Jais, Corinne Haioun, Bertrand Coiffier, and Franck Morschhauser Blood Volume 118(1):37-43 July 7, 2011 ©2011 by American Society of Hematology

2. Scheme of the treatment according to the LNH2007-3B trial. René-Olivier Casasnovas et al. Blood 2011;118:37-43 ©2011 by American Society of Hematology

3. PFS of 85 patients. René-Olivier Casasnovas et al. Blood 2011;118:37-43 ©2011 by American Society of Hematology

4. PFS of 84 patients. René-Olivier Casasnovas et al. Blood 2011;118:37-43 ©2011 by American Society of Hematology

5. Effect of postinduction treatment on patients' PFS. Effect of postinduction treatment on patients' PFS according to (A) PET-driven postinduction treatment and (B) PET-driven postinduction treatment and SUVmax reduction analysis. René-Olivier Casasnovas et al. Blood 2011;118:37-43 ©2011 by American Society of Hematology